Gregson NA, Kennedy M, Leibowitz S. The specificity of anti-galactocerebroside antibody and its reaction with lysolecithin-solubilized myelin.
Immunology 1974;
26:743-57. [PMID:
4212453 PMCID:
PMC1423180]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Antibody to galactocerebroside can be produced in rabbits by the injection of the hapten together with a carrier protein (GC.BSA) or by immunization with the myelin fraction of brain homogenates (GC.M). The anti-galactocerebroside activity of both sera is mainly directed towards the galactose moiety of the galactolipid. In a complement fixation system they react with galactocerebroside (galactosylceramide) and monogalactosyldiglyceride, but not with glucocerebroside (glucosylceramide).
Passive cutaneous anaphylaxis can be elicited by the carrier, but not the hapten. There is no demonstrable reaction to the glycolipid itself—even when tested in association with auxiliary lipids or the carrier protein; or as a component of solubilized myelin.
The specificity of antibody to galactocerebroside appears to be unaffected by the nature of the carrier or associated proteins. This is shown by the fact that antisera to GC.BSA and GC.M react in an identical fashion with the lipid—protein complexes formed when myelin is solubilized with lysolecithin. Complement fixation is increased by solubilization, but increasing the lysolecithin/myelin ratio above the minimum necessary to render myelin completely soluble decreased the specific activity. Following isopycnic centrifugation maximum complement fixing activity was present in a fraction having a density of 1.04 at 10°, corresponding to one of three peaks of galactocerebroside concentration. However, precipitin reactions were obtained over a range of fractions of higher density.
These results suggest that galactocerebroside is present in myelin in at least two forms and provides further confirmation of the fact that this hapten is responsible for a large part of the organ-specific complement fixing and precipitating activity of anti-myelin serum.
Collapse